Job Search

You will be prompted to create an account when you apply for a position. Already have an account? Log in here.

Position Type




Postdoctoral Research Fellow

Apply now Job no: 507711
Position Type: Staff
Location: Boston Main Campus
Categories: Bouve College of Health Sciences

About Northeastern:

Founded in 1898, Northeastern is a global research university and the recognized leader in experience-driven lifelong learning. Our world-renowned experiential approach empowers our students, faculty, alumni, and partners to create impact far beyond the confines of discipline, degree, and campus.

Our locations—in Boston; Charlotte, North Carolina; London; Portland, Maine; San Francisco; Seattle; Silicon Valley; Toronto; Vancouver; and the Massachusetts communities of Burlington and Nahant—are nodes in our growing global university system. Through this network, we expand opportunities for flexible, student-centered learning and collaborative, solutions-focused research.

Northeastern’s comprehensive array of undergraduate and graduate programs— in a variety of on-campus and online formats—lead to degrees through the doctorate in nine colleges and schools. Among these, we offer more than 195 multi-discipline majors and degrees designed to prepare students for purposeful lives and careers.


About the Opportunity:

About Deciphera Pharmaceuticals:

Deciphera Pharmaceuticals is a commercial biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates in clinical studies, QINLOCK® is Deciphera’s first FDA-approved drug, a switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumor (GIST). QINLOCK, an oral oncolytic, is also approved in Canada, Australia, Hong Kong, and China for the treatment of fourth-line GIST.

Deciphera (NASDAQ: DCPH) is a publicly traded company headquartered in Waltham, Massachusetts. Our state-of-the-art research facility is located in Lawrence, Kansas.

We offer an outstanding culture and opportunity for personal and professional growth based on our “PATHS” Core Values:

- Patients – places the importance of improving the lives of patients and their caregivers at the forefront of every day’s work.

- Accountability – for our performance and the way we work with coworkers and other stakeholders.

- Transparency – in our intent and actions to both internal and external stakeholders.

- Honesty and Integrity – fosters trust and strives to deliver on our and the company’s promises. - Stewardship – values and uses wisely the resources and investments provided to the company.

Deciphera’s Science and Pipeline:

Deciphera is developing novel small molecule drug candidates to improve the lives of cancer patients by addressing key mechanisms of tumor and drug resistance that limit the effectiveness of many cancer therapies. Our pipeline of drug candidates is designed to stop cancers from growing and spreading by inhibiting mutant forms or over expression of a family of enzymes called kinase. Enabled by our proprietary kinase switch control inhibitor drug discovery platform, we have developed kinase switch control inhibitors that interact at a molecular level in a way that is distinct from other kinase inhibitors and are designed to generate higher and more durable rates of response.

We have developed a diverse pipeline of differentiated, orally administered, oncology drug candidates that includes, among others, our approved product, QINLOCK (ripretinib), a broad-spectrum KIT and PDGFRA kinase switch control inhibitor is approved for the treatment of fourth-line GIST. Our follow-on study of ripretinib, the INTRIGUE study, is a pivotal Phase 3 trial in second-line GIST. We also have three additional clinical-stage programs for drug candidates DCC-3116, vimseltinib, and rebastinib. Several research-stage programs are in the pipeline as well.




The two-year Fellowship Program in collaboration with Northeastern University and Deciphera Pharmaceuticals is designed to offer Doctor of Pharmacy graduates an in-depth experience in a biopharmaceutical industry setting. The core mission of the Deciphera Pharmaceuticals Medical Affairs team is to generate and communicate clinical and scientific data and engage key stakeholders, including healthcare professionals, researchers, patient advocacy groups, and payers to ultimately improve the lives of patients diagnosed with cancer. The Medical Affairs Fellow will gain valuable experience as an integral member of the Deciphera Pharmaceuticals Medical Affairs team through a rotation-based program.

The fellow will have cross-functional exposure, broad hands-on experiences, dedicated mentorship, and longitudinal core responsibilities. The fellow will also participate in key Medical Affairs Launch and Pre-Launch Activities.

Core departmental rotations include, but are not limited to, Medical Information, Publications,), Expanded Access Program (EAP), Medical Operations, Health Economics and Outcomes Research (HEOR), and Field Medical/External Affairs. The fellow will also have the opportunity to pursue elective rotations outside of Medical Affairs based on interest and company needs in order to enhance learning and personal growth.

Roles and Responsibilities:

Plan and develop medical information letters and scientific communication materials

Compile data, feedback, and metrics on medical information activities to support medical insight generation

Publications support by strategically identifying data gaps, developing, and executing publication plan

Attend medical congresses to gather medical insights and support the medical booth

Work with regulatory, compliance, and medical director to review medical and promotional materials for medical accuracy

Support in the planning and execution of advisory boards

Develop evidence dossiers for use by key healthcare decision makers

Work with the Field Medical Science Liaison team (MSL) to gain an understanding of key opinion leader engagement and territory management

Assist with management of Expanded Access program (EAP), review of medical education grants proposals, medical training, congress planning, and Investigator-Sponsored Research Review Committees

Gain insights into medical strategy  planning & execution


Doctor of Pharmacy degree from an ACPE accredited institution, eligible for licensure as a pharmacist in the State of Massachusetts.

Preferred Qualifications:

 Excellent oral and written communication, time management, and leadership skills, ability to work independently and take initiative on a variety of projects at the industry site and Northeastern.


Salary Grade:


Additional Information:

Applicants should submit the following APPLICATION MATERIALS by the priority deadline of November 1st , 2021:

  1. Curriculum vitae (CV), uploaded
  2. Unofficial PharmD transcripts, uploaded
  3. Cover letter, uploaded

Three formal letters of recommendation (LORs) sent directly from the letter writer to by November 29th, 2021. LOR writers should include the candidate’s name and fellowship program(s) in the subject line (e.g. Smith, John – Alnylam, GSK).


Address cover letter and three LORs to:

J. Andrew Orr-Skirvin, PharmD, BCOP

Clinical Professor, School of Pharmacy

Chair, Department of Pharmacy & Health System Sciences

Director of Pharmaceutical Industry Fellowship Program

360 Huntington Ave, 140TF R218

Boston, MA 02115

Advertised: Eastern Daylight Time
Applications close: Eastern Standard Time

Back to search results Apply now Refer a friend

Share this:

| More